Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema

Fidan Yıldız (Izmir, Turkey), Fidan Yildiz, Inanc Karapolat, Güray Oncel

Source: International Congress 2016 – Airway stenting and ablation
Session: Airway stenting and ablation
Session type: Thematic Poster
Number: 3848
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fidan Yıldız (Izmir, Turkey), Fidan Yildiz, Inanc Karapolat, Güray Oncel. Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema. Eur Respir J 2016; 48: Suppl. 60, 3848

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

Quantitative CT (QCT) analysis of emphysema and air trapping in coil-based lung volume reduction (LVRC) treatment
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Lung volume reduction coil (LVRC) treatment is safe and effective in heterogeneous and homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013

Comparison of software based CT fissure analyses and endobronchial in-vivo measurements for detection of collateral ventilation for endoscopic lung volume reduction
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR)
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015


Dynamic hyperinflation after bronchial lung volume reduction: An expected effect or perhaps a preoperative test for selection?
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Endoscopic lung volume reduction (ELVR) in COPD: A comparison between two endobronchial valves systems
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


CT assessment of lobar heterogenity and fissure integrity in pulmonary emphysema for bronchoscopic lung volume reduction with valve
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015


Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012



Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

The minimal important difference for target lobe volume reduction following endoscopic valve therapy in patients with advanced emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

CT predictors of VQ perfusion: Application to endobronchial valve lung reduction treatment
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015

6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013